Do indica and sativa labels matter when it comes to cannabis?
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
24 results for “indica”
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
Sean McKinley of Originals CBD explores the emerging dangers of synthetic and semi-synthetic cannabinoids in Europe, both for businesses and consumers.
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
Germany has voted to ban medical cannabis flower from its statutory health insurance scheme.
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
Introducing The Medical Cannabis Employer Handbook
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
People who consumed THC were more likely to recall words that were never shown to them.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
A comprehensive guide on how to read and interpret cannabis research.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.